PL2049480T3 - Pochodne 2-aryloindolu jako inhibitory mPGES-1 - Google Patents
Pochodne 2-aryloindolu jako inhibitory mPGES-1Info
- Publication number
- PL2049480T3 PL2049480T3 PL07786740T PL07786740T PL2049480T3 PL 2049480 T3 PL2049480 T3 PL 2049480T3 PL 07786740 T PL07786740 T PL 07786740T PL 07786740 T PL07786740 T PL 07786740T PL 2049480 T3 PL2049480 T3 PL 2049480T3
- Authority
- PL
- Poland
- Prior art keywords
- mpges
- inhibitors
- arylindole derivatives
- arylindole
- derivatives
- Prior art date
Links
- 101710096361 Prostaglandin E synthase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001368A ITMI20061368A1 (it) | 2006-07-14 | 2006-07-14 | Composto 2-arilindolico sostituito in posizione 5, composizione farmaceutica che lo comprende nonche' composti intermedi e procedimento per prepararlo |
| PCT/EP2007/055901 WO2008006663A1 (en) | 2006-07-14 | 2007-06-14 | 2-arylindole derivatives as npges-i inhibitors |
| EP07786740.6A EP2049480B1 (en) | 2006-07-14 | 2007-06-14 | 2-ARYLINDOLE DERIVATIVES AS mPGES-1 INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2049480T3 true PL2049480T3 (pl) | 2014-03-31 |
Family
ID=37895798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07786740T PL2049480T3 (pl) | 2006-07-14 | 2007-06-14 | Pochodne 2-aryloindolu jako inhibitory mPGES-1 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8017644B2 (pl) |
| EP (1) | EP2049480B1 (pl) |
| JP (1) | JP5302191B2 (pl) |
| KR (2) | KR101440015B1 (pl) |
| CN (1) | CN101490000B (pl) |
| AR (1) | AR061973A1 (pl) |
| AU (1) | AU2007271865B2 (pl) |
| BR (1) | BRPI0712889A8 (pl) |
| CA (1) | CA2655750C (pl) |
| DK (1) | DK2049480T3 (pl) |
| EA (1) | EA015689B1 (pl) |
| ES (1) | ES2441594T3 (pl) |
| GE (1) | GEP20115166B (pl) |
| IL (1) | IL196000A (pl) |
| IT (1) | ITMI20061368A1 (pl) |
| MX (1) | MX2009000492A (pl) |
| PL (1) | PL2049480T3 (pl) |
| PT (1) | PT2049480E (pl) |
| SI (1) | SI2049480T1 (pl) |
| UA (1) | UA96759C2 (pl) |
| WO (1) | WO2008006663A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2078711A1 (en) * | 2007-12-28 | 2009-07-15 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| WO2010114896A1 (en) | 2009-03-31 | 2010-10-07 | Arqule, Inc. | Substituted indolo-pyridinone compounds |
| WO2011077313A1 (en) | 2009-12-22 | 2011-06-30 | Pfizer Inc. | Piperidinecarboxamides as mpges - 1 inhibitors |
| UA108950C2 (uk) * | 2011-08-18 | 2015-06-25 | Гетероциклічна похідна і фармацевтичний засіб | |
| WO2013038308A1 (en) * | 2011-09-15 | 2013-03-21 | Glenmark Pharmaceuticals S.A. | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS |
| RU2681537C2 (ru) * | 2014-04-14 | 2019-03-07 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение |
| EP3178810A4 (en) * | 2014-08-08 | 2018-07-04 | Kasuma Partners Inc. | Condensed heterocyclic compound |
| PT3762368T (pt) | 2018-03-08 | 2022-05-06 | Incyte Corp | Compostos de aminopirazina diol como inibidores de pi3k-y |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| JP7337260B2 (ja) * | 2019-08-26 | 2023-09-01 | クッジェ ファーマ カンパニー，リミテッド | インドールカルボキサミド誘導体及びそれを含む薬剤学的組成物 |
| WO2021231474A1 (en) * | 2020-05-12 | 2021-11-18 | Pmv Pharmaceuticals, Inc. | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003270426A1 (en) * | 2002-09-12 | 2004-04-30 | Avanir Pharmaceuticals | PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| CA2515516A1 (en) | 2003-02-07 | 2004-08-19 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid compounds |
| CA2536870C (en) * | 2003-09-03 | 2009-10-27 | Pfizer Inc. | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| ITTO20040125A1 (it) * | 2004-03-01 | 2004-06-01 | Rotta Research Lab | Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica |
| GB0410121D0 (en) * | 2004-05-06 | 2004-06-09 | Glaxo Group Ltd | Compounds |
-
2006
- 2006-07-14 IT IT001368A patent/ITMI20061368A1/it unknown
-
2007
- 2007-06-14 US US12/306,426 patent/US8017644B2/en not_active Expired - Fee Related
- 2007-06-14 DK DK07786740.6T patent/DK2049480T3/da active
- 2007-06-14 EP EP07786740.6A patent/EP2049480B1/en active Active
- 2007-06-14 SI SI200731381T patent/SI2049480T1/sl unknown
- 2007-06-14 PT PT77867406T patent/PT2049480E/pt unknown
- 2007-06-14 PL PL07786740T patent/PL2049480T3/pl unknown
- 2007-06-14 JP JP2009518814A patent/JP5302191B2/ja not_active Expired - Fee Related
- 2007-06-14 EA EA200970124A patent/EA015689B1/ru not_active IP Right Cessation
- 2007-06-14 KR KR1020097003017A patent/KR101440015B1/ko not_active Expired - Fee Related
- 2007-06-14 CA CA2655750A patent/CA2655750C/en not_active Expired - Fee Related
- 2007-06-14 AU AU2007271865A patent/AU2007271865B2/en not_active Ceased
- 2007-06-14 BR BRPI0712889A patent/BRPI0712889A8/pt not_active IP Right Cessation
- 2007-06-14 MX MX2009000492A patent/MX2009000492A/es active IP Right Grant
- 2007-06-14 KR KR1020147014551A patent/KR20140091569A/ko not_active Ceased
- 2007-06-14 ES ES07786740.6T patent/ES2441594T3/es active Active
- 2007-06-14 UA UAA200814463A patent/UA96759C2/ru unknown
- 2007-06-14 CN CN200780026647XA patent/CN101490000B/zh not_active Expired - Fee Related
- 2007-06-14 WO PCT/EP2007/055901 patent/WO2008006663A1/en not_active Ceased
- 2007-06-14 GE GEAP200711112A patent/GEP20115166B/en unknown
- 2007-07-12 AR ARP070103095A patent/AR061973A1/es not_active Application Discontinuation
-
2008
- 2008-12-17 IL IL196000A patent/IL196000A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0712889A2 (pt) | 2012-10-09 |
| SI2049480T1 (sl) | 2014-02-28 |
| HK1124068A1 (en) | 2009-08-07 |
| DK2049480T3 (da) | 2014-01-20 |
| IL196000A (en) | 2013-10-31 |
| UA96759C2 (en) | 2011-12-12 |
| GEP20115166B (en) | 2011-02-25 |
| BRPI0712889A8 (pt) | 2018-01-02 |
| WO2008006663A1 (en) | 2008-01-17 |
| AU2007271865A1 (en) | 2008-01-17 |
| PT2049480E (pt) | 2013-12-16 |
| CA2655750A1 (en) | 2008-01-17 |
| CN101490000B (zh) | 2012-10-03 |
| JP2009543766A (ja) | 2009-12-10 |
| CN101490000A (zh) | 2009-07-22 |
| EP2049480B1 (en) | 2013-10-30 |
| US20090186922A1 (en) | 2009-07-23 |
| EA200970124A1 (ru) | 2009-06-30 |
| IL196000A0 (en) | 2009-09-01 |
| ES2441594T3 (es) | 2014-02-05 |
| AU2007271865B2 (en) | 2013-02-21 |
| KR20140091569A (ko) | 2014-07-21 |
| ITMI20061368A1 (it) | 2008-01-15 |
| KR101440015B1 (ko) | 2014-09-12 |
| KR20090054962A (ko) | 2009-06-01 |
| EP2049480A1 (en) | 2009-04-22 |
| AR061973A1 (es) | 2008-08-10 |
| JP5302191B2 (ja) | 2013-10-02 |
| EA015689B1 (ru) | 2011-10-31 |
| CA2655750C (en) | 2014-09-09 |
| US8017644B2 (en) | 2011-09-13 |
| MX2009000492A (es) | 2009-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL198247A0 (en) | Indazole derivatives useful as l-cpt1 inhibitors | |
| ZA200807748B (en) | Dihydropyrazolopyrimidinone derivatives | |
| ZA200901336B (en) | Pyridizinone derivatives | |
| IL193641A0 (en) | Spiroindolinone derivatives | |
| IL195013A0 (en) | Pyridopyrimidinone derivatives | |
| IL198319A0 (en) | Spiroindolinone derivatives | |
| IL195422A0 (en) | 2-pyrazinecarboxamide derivatives | |
| IL192603A0 (en) | Thieno-pyridine derivatives as mek inhibitors | |
| IL200047A0 (en) | Pyrazole derivatives as 11-beta-hsd1 inhibitors | |
| ZA200805574B (en) | Indol-3-yl-carbonyl-spiro-piperidine derivatives | |
| ZA200809800B (en) | 2-Thioxanthine derivatives acting as Mpo-inhibitors | |
| SI2078001T1 (sl) | Derivati diazepan-acetamida kot selektivni zaviralci 11 -hsd1 | |
| IL198059A0 (en) | 2-aminocarbonyl-pyridine derivatives | |
| IL196364A0 (en) | Aminoindazolylurea derivatives | |
| PL2049480T3 (pl) | Pochodne 2-aryloindolu jako inhibitory mPGES-1 | |
| IL193211A0 (en) | Indazole-heteroaryl derivatives | |
| IL198645A0 (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives | |
| IL197152A0 (en) | 5-phenyl-nicotinamide derivatives | |
| GB0622472D0 (en) | Novel heterocyclic derivatives | |
| ZA200807460B (en) | Spiroindolinone derivatives | |
| IL197239A0 (en) | Phenyloxyaniline derivatives | |
| ZA200905235B (en) | Pyrazole derivatives as 11-beta-hsd1 inhibitors | |
| GB0614154D0 (en) | Novel Pyriazine Derivatives | |
| ZA200903280B (en) | 2-aminocarbonyl-pyridine derivatives | |
| GB0624214D0 (en) | Benzotriazepinone derivatives |